• Home
  • Search Results

Search Results

432 studies match your search
Open

Cancer Research Study for Bertie, Hertford, Robeson & Scotland Co, NC and neighboring counties

We are seeking volunteers for a survey to learn what may encourage and discourage cancer patients to be in cancer research studies. We'd like to hear from you if you are: -18 years+ -Have been diagnosed with cancer or the caregiver of someone diagnosed with cancer. -Spend time in Bertie, Hertford, Robeson or Scotland County, NC or a neighboring county. Participation includes 1 survey (about 10 minutes long) that can be done with your mobile device, computer, or by phone with the researcher. Compensation: 1 in 10 participants will receive a $25 Visa gift card.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Brain and Other Nervous System, Breast, and 20 more)
Visit Location
100% Remote (online, phone, text)

Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With Recurrent or Refractory Hodgkin Lymphoma and CD-30 Positive Peripheral T-Cell Lymphoma (LuminICE-203)

This study enrolling people who recurrent (has come back) or refractory (did not respond to treatment) classical Hodgkin lymphoma or CD30-positive peripheral T-cell lymphoma (PTCL). The purpose of this study is to learn about the effectiveness and safety of a new study drug called AFM13 when used in combination with a new cell therapy called AB-101. The study will also look at how the body processes this combination of drugs (called "pharmacokinetics").

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

Administration of T Cells Expressing CAR in Subjects with Head and Neck Squamous Cell Carcinoma

Have you been diagnosed with Squamous cell carcinoma. Are you looking for options to treat your cancer ? If so, you may be able to take part in a research study looking at the safety of giving a new drug called iC9-CAR.CSPG4 and Rimiducid to patients with squamous cell carcinoma

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Open

Tissue Sample Study (CYBRID-02)

Are you scheduled for or planning to have a biopsy done at UNC Health? For this trial, we are looking for people who are 18 years or older who are suspected or diagnosed with Stage IV/metastatic cancer, including: • Lung: Non-small cell lung cancer (NSCLC), • Head and Neck: Squamous Cell Carcinoma (HSNCC), excluding nasopharyngeal and salivary gland cancer; • Kidney: Clear Cell Renal Cell Carcinoma (ccRCC); • Bladder: Urothelial Carcinoma (UC); Skin: Cutaneous Melanoma, excluding Uveal Melanoma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Head and Neck, Kidney, and 3 more)
Not currently enrolling

Financial Assistance Research

We would like to learn about how people who apply for healthcare financial assistance experience the application process, including things that make the application process work well or that were challenging. At this time we are not able to offer interviews to people who applied to UNC or Duke, we are interested in hearing from people who applied to other programs (such as Atrium, Novant, Wake, Vidant, ECU, Cape Fear Health Net, Physicians Reach Out, or Project Access).

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Behavior
  • Blood Pressure
  • and 44 more
Visit Location
100% Remote (online, phone, text)
Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)

Young Adult Cancer Survivors Healthy Eating and Active Lifestyle Study

We are doing this study to test a behavioral lifestyle program designed specifically for adolescent and young adult cancer survivors. Study participants will use a smartphone app and Fitbit activity tracker to help them develop healthier habits.

Age & Gender
  • 18 years ~ 39 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Eating, Nutrition, and Metabolism
  • Wellness and Lifestyle
  • and 3 more
Visit Location
100% Remote (online, phone, text)
Open

Pro00107408

Do you have metastatic renal cell carcinoma? If so, you may be able to take part in a research study collecting information about how your therapy is affecting your quality of life.

Age & Gender
  • 19 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Kidney)
Open

Stage III Colon Cancer Study

Do you have stage III colon cancer? Have you already completed surgery? If so, you may qualify for a study that uses a blood test called ctDNA to determine your treatment and to monitor for recurrence.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Colorectal)
Open

A US study to evaluate transarterial radioembolization (TARE) in combination with durvalumab and bevacizumab therapy in people with hepatocellular carcinoma amenable to TARE

Have you been diagnosed with Liver cancer. If so, you may be able to take part in a research study looking to to measure the efficacy and safety of durvalumab IV solution plus bevacizumab IV solution after transarterial radioembolization(Y90 glass microsphere TARE) in participants with unresectable HCC amenable to locoregional therapy

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Liver)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research